Home LiteratureArticle Details
PMID: 2201749 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Evidence of widespread binding of HLA class I molecules to peptides.

The Journal of experimental medicine ·Vol. 172 ·No. 3 ·1990-09-01 ·Pages 827-34

Frelinger JA, Gotch FM, Zweerink H, Wain E, McMichael AJ

Abstract

We have tested the binding of HLA class I proteins to peptides using a solid-phase binding assay. We tested 102 peptides, mostly derived from the HIV gag and HIV pol sequences. Most peptides did not bind to any class I protein tested. The pattern of binding among the three class I proteins tested, HLA-A2, -B27, and -B8, was approximately 85% concordant. Further, all five of the known HIV-1 gag T cell epitopes detected by human CTL bound at least one class I protein. Binding of class I to the peptides could be detected either by directly iodinated class I proteins, or indirectly using monoclonal antibodies specific for class I. The binding to the plates could be blocked with MA2.1, which binds in the alpha 1 region of A2, but not by W6/32, which binds elsewhere. The data presented here show that binding of class I to peptides is specific, but that many peptides bind to more than a single class I protein.

MeSH Terms
Amino Acid Sequence Antibodies, Monoclonal Cell Line Gene Products, gag/immunology Gene Products, pol/immunology HIV/immunology HIV-1/immunology Histocompatibility Antigens Class I/immunology,isolation & purification Humans Kinetics Molecular Sequence Data Peptide Fragments/immunology Protein Binding
Chemicals
Antibodies, Monoclonal Gene Products, gag Gene Products, pol Histocompatibility Antigens Class I Peptide Fragments
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Frelinger J A
Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, United Kingdom.
Gotch F M
Zweerink H
Wain E
McMichael A J
References (20)
20 references, click to expand
  1. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis.
    Cell. 1978 May;14(1):9-20 PMID: 667938
  2. Comparison between two peptide epitopes presented to cytotoxic T lymphocytes by HLA-A2. Evidence for discrete locations within HLA-A2.
    J Immunol. 1989 Dec 15;143(12):4098-103 PMID: 2480387
  3. A monoclonal antibody that recognizes an antigenic determinant shared by HLA A2 and B17.
    Hum Immunol. 1980 Sep;1(2):121-9 PMID: 6167544
  4. Definition of four HLA-A2 subtypes by CML typing and biochemical analysis.
    Immunogenetics. 1983;17(6):609-21 PMID: 6407985
  5. Binding of immunogenic peptides to Ia histocompatibility molecules.
    Nature. 1985 Sep 26-Oct 2;317(6035):359-61 PMID: 3876513
  6. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.
    Cell. 1986 Mar 28;44(6):959-68 PMID: 2420472
  7. Isolation and characterization of antigen-Ia complexes involved in T cell recognition.
    Cell. 1986 Dec 26;47(6):1071-7 PMID: 3490919
  8. The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides.
    Science. 1987 Mar 13;235(4794):1353-8 PMID: 2435001
  9. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2.
    Nature. 1987 Apr 30-May 6;326(6116):881-2 PMID: 2437457
  10. Molecular characterization of serologic recognition sites in the human HLA-A2 molecule.
    J Immunol. 1988 Oct 15;141(8):2811-8 PMID: 2459229
  11. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides.
    Nature. 1988 Dec 1;336(6198):484-7 PMID: 2461519
  12. Effect of mutations and variations of HLA-A2 on recognition of a virus peptide epitope by cytotoxic T lymphocytes.
    Proc Natl Acad Sci U S A. 1988 Dec;85(23):9194-8 PMID: 2461564
  13. Recognition of influenza A matrix protein by HLA-A2-restricted cytotoxic T lymphocytes. Use of analogues to orientate the matrix peptide in the HLA-A2 binding site.
    J Exp Med. 1988 Dec 1;168(6):2045-57 PMID: 3264322
  14. Influenza-specific cytotoxic T-cell recognition is inhibited by peptides unrelated in both sequence and MHC restriction.
    Immunology. 1989 Feb;66(2):163-9 PMID: 2466767
  15. HLA-B37 and HLA-A2.1 molecules bind largely nonoverlapping sets of peptides.
    Proc Natl Acad Sci U S A. 1990 May;87(9):3420-4 PMID: 2333291
  16. Apparent lack of MHC restriction in binding of class I HLA molecules to solid-phase peptides.
    J Exp Med. 1990 Sep 1;172(3):931-6 PMID: 1696957
  17. Murine MHC polymorphism and T cell specificities.
    Science. 1989 May 5;244(4904):572-5 PMID: 2470147
  18. Physical association between MHC class I molecules and immunogenic peptides.
    Nature. 1989 Jun 8;339(6224):473-5 PMID: 2786149
  19. Association of class I major histocompatibility heavy and light chains induced by viral peptides.
    Nature. 1989 Aug 10;340(6233):443-8 PMID: 2666863
  20. MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness.
    Adv Immunol. 1979;27:51-177 PMID: 92183
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1990-09-01
Pages
827-34
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2188539
Subset
IM
Grants
NIAID NIH HHS · AI-20288 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]